Recent Events & Catalysts
Guardant Health, Inc. (GH) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Guardant Health: Screening And MRD Are Just Getting Started
SeekingAlpha · today
Caris Life Sciences: Guidance Raised, Valuation Still Attractive
SeekingAlpha · 4d ago
Alger Small Cap Focus Fund Q2 2026 Portfolio Review
SeekingAlpha · 5d ago
Piper Sandler Maintains Overweight on Guardant Health, Raises Price Target to $193
Benzinga · 7d ago
Stephens & Co. Maintains Overweight on Guardant Health, Raises Price Target to $195
Benzinga · 7d ago
Morgan Stanley Maintains Overweight on Guardant Health, Raises Price Target to $185
Benzinga · 7d ago
Stifel Maintains Buy on Guardant Health, Raises Price Target to $180
Benzinga · 8d ago
RBC Capital Maintains Outperform on Guardant Health, Raises Price Target to $200
Benzinga · 11d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-07-30 · 12d ago · Material
Submission of matters to a vote of security holders
Filed 2026-06-18 · 54d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.